BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36156132)

  • 21. Perspectives on testicular germ cell neoplasms.
    Cheng L; Lyu B; Roth LM
    Hum Pathol; 2017 Jan; 59():10-25. PubMed ID: 27569298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours.
    Bagrodia A; Savelyeva A; Lafin JT; Speir RW; Chesnut GT; Frazier AL; Woldu SL; Margulis V; Murray MJ; Amatruda JF; Lotan Y
    BJU Int; 2021 Jul; 128(1):57-64. PubMed ID: 33124175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum tumour markers in germ cell tumours: From diagnosis to cure.
    Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
    Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological risk factors for higher clinical stage in testicular seminomas.
    Trevino KE; Esmaeili-Shandiz A; Saeed O; Xu H; Ulbright TM; Idrees MT
    Histopathology; 2018 Nov; 73(5):741-747. PubMed ID: 29858564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A; Hennig F; Ikogho R; Hammel J; Anheuser P; Wülfing C; Belge G; Dieckmann KP
    Urol Int; 2018; 100(4):470-475. PubMed ID: 29698973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review.
    Fankhauser CD; Nuño MM; Murray MJ; Frazier L; Bagrodia A
    Eur Urol Focus; 2022 May; 8(3):660-662. PubMed ID: 35537936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy.
    Kliesch S; Schmidt S; Wilborn D; Aigner C; Albrecht W; Bedke J; Beintker M; Beyersdorff D; Bokemeyer C; Busch J; Classen J; de Wit M; Dieckmann KP; Diemer T; Dieing A; Gockel M; Göckel-Beining B; Hakenberg OW; Heidenreich A; Heinzelbecker J; Herkommer K; Hermanns T; Kaufmann S; Kornmann M; Kotzerke J; Krege S; Kristiansen G; Lorch A; Müller AC; Oechsle K; Ohloff T; Oing C; Otto U; Pfister D; Pichler R; Recken H; Rick O; Rudolph Y; Ruf C; Schirren J; Schmelz H; Schmidberger H; Schrader M; Schweyer S; Seeling S; Souchon R; Winter C; Wittekind C; Zengerling F; Zermann DH; Zillmann R; Albers P
    Urol Int; 2021; 105(3-4):181-191. PubMed ID: 33486494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
    Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stage-specific treatment for testicular germ cell tumours].
    Heidenreich A; Bokemeyer C; Souchon R
    Urologe A; 2009 Apr; 48(4):377-85. PubMed ID: 19252891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
    Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G
    Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CCAFU Recommendations 2013: Testicular germ cell cancer].
    Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
    Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.
    Mosbech CH; Svingen T; Nielsen JE; Toft BG; Rechnitzer C; Petersen BL; Rajpert-De Meyts E; Hoei-Hansen CE
    Virchows Arch; 2014 Nov; 465(5):567-77. PubMed ID: 25074678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
    Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
    Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
    Krege S; Albers P; Heidenreich A
    Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germ cell tumours of testis: prognostic factors and results.
    Nikzas D; Champion AE; Fox M
    Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-surgical treatment of testicular cancer: guidelines for the urologist].
    Páez Borda A; Llorente Abarca C; Herrero Payo A; Acebal Lucia J; Berenguer Sánchez A
    Actas Urol Esp; 1993 Apr; 17(4):226-33. PubMed ID: 8393610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia.
    Ruf CG; Gnoss A; Hartmann M; Matthies C; Anheuser P; Loy V; Pichlmeier U; Dieckmann KP
    Andrology; 2015 Jan; 3(1):92-8. PubMed ID: 25146646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.